Compare CBUS & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CBUS | SEER |
|---|---|---|
| Founded | 2010 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Agricultural Chemicals | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 121.1M | 97.3M |
| IPO Year | 2017 | 2020 |
| Metric | CBUS | SEER |
|---|---|---|
| Price | $1.51 | $1.98 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | ★ 799.0K | 347.8K |
| Earning Date | 05-07-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 74.33 | 9.40 |
| EPS | N/A | ★ N/A |
| Revenue | $3,639,000.00 | ★ $16,578,000.00 |
| Revenue This Year | $112.72 | $2.14 |
| Revenue Next Year | $83.18 | $25.90 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 16.99 |
| 52 Week Low | $1.09 | $1.65 |
| 52 Week High | $4.19 | $2.41 |
| Indicator | CBUS | SEER |
|---|---|---|
| Relative Strength Index (RSI) | 37.44 | 63.86 |
| Support Level | $1.46 | $1.87 |
| Resistance Level | $1.59 | $2.13 |
| Average True Range (ATR) | 0.17 | 0.06 |
| MACD | 0.03 | 0.03 |
| Stochastic Oscillator | 31.88 | 80.52 |
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.